Avacta is one of the few Biotech shares which have not tanked in recent months. The agreement with Modern of America is very important.They have been rated as the most dynamic Bio company in America. The recent funding operation provides the cash to build the company.The appointment of Dr Mike Owen as non executive director gives Avacta the clout it needs to promote Affirmas.Dr Owen is involved with BillGates and Neil Woodford so he has excellent contacts. Be happy
I think that if you look at Avacta realistically, it has not been a very good investment up to now and even though I am in profit, it's taken six years to get there. If I had had more faith in my own judgement and kept DIA, GNC and TRAK, I would now be seriously rich, but I didn't, and instead put the money into Avacta. PIs and indeed major investors that have been looking at Avacta will probably dismiss it as a jam tomorrow share and will be using their money elsewhere and will probably not be afraid to miss the first big rise. However, I don't want to miss it, which is why I am staying where I am. It's taken a lot of patience and maybe foolishness to stay the course with Avacta, but, this is an opportunity to be in at the very beginning of what I consider to be a very exciting company and when the time is right the sp will go up and patience will be rewarded. On the other hand, If none of this happens, then it'll be my tough luck and I'll have to accept that.
It's not actually news. If you follow Avacta on face book, you get all this kind of info a little earlier. I don't think the sp will go anywhere until there have been some serious sales of Affimers, which I think will only happen when the Cambridge facility is up and running. I do believe that AVCT has yet to make a profit.
... is still well under the radar which might not be such a bad thing. I would dearly like the sp to stay where it is until April 2016 where we can load up our ISAs with more chunks of dosh to make the most of what I am sure will be a multi-bagger in the not too distant future. In fact, things could work out very well with the Cambridge production facility being completed in early 2016. I don't think hat there will be a big reaction to the Oct 26th prelims, but the Feb 8th trading update may cause a bit of a stir. Certainly 2016 could see the start of some serious sp movement.
The Luminax news added to the agreement with Moderna Therapeutics of America demonstrates the potential for Affirmas worldwide.Moderna are regarded as the most exciting pharma company in the United States.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.